Demir, Y. Et Al. 2023. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Archiv der Pharmazie , vol.356, no.4 .

Demir, Y., TÜRKEŞ, C., Çavuş, M. S., Erdoğan, M., Muğlu, H., Yakan, H., ... BEYDEMİR, Ş.(2023). Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Archiv der Pharmazie , vol.356, no.4.

Demir, Yeliz Et Al. "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif," Archiv der Pharmazie , vol.356, no.4, 2023

Demir, Yeliz Et Al. "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif." Archiv der Pharmazie , vol.356, no.4, 2023

Demir, Y. Et Al. (2023) . "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif." Archiv der Pharmazie , vol.356, no.4.

@article{article, author={Yeliz Demir Et Al. }, title={Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif}, journal={Archiv der Pharmazie}, year=2023}